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Background: The therapeutic effects of the Amazonian plant tea ayahuasca may relate
to its ability to enhance mindfulness capacities. Ayahuasca induces a modified state
of awareness through the combined action of its active principles: the psychedelic
N,N-dimethyltryptamine (DMT) and a series of centrally acting β-carbolines, mainly
harmine and tetrahydroharmine. To better understand the therapeutic potential of
ayahuasca, here we compared the impact on mindfulness capacities induced by two
independent interventions: (a) participation in four ayahuasca sessions without any
specific purpose related to improving mindfulness capacities; and (b) participation in
a standard mindfulness training course: 8 weeks mindfulness-based stress reduction
(MBSR), with the specific goal of improving these skills.
Methods: Participants of two independent groups completed two self-report
instruments: The Five Facet Mindfulness Questionnaire (FFMQ) and the Experiences
Questionnaire (EQ). The MINDSENS Composite Index was also calculated, including
those EQ and FFMQ items that have proven to be the most sensitive to meditation
practice. Group A (n = 10) was assessed before and after the last of four closely spaced
consecutive ayahuasca sessions. Group B (n = 10) was assessed before and after
completion of a standard 8-week MBSR course.
Results: MBSR training led to greater increases in overall mindfulness scores after
the 8-week period. MBSR but not ayahuasca led to increases in the MINDSENS
Composite Index. However, the ayahuasca sessions induced comparable increases in
the Non-Judging subscale of the FFMQ, specifically measuring “acceptance.” Improving
this capacity allows for a more detached and less judgmental stance toward potentially
distressing thoughts and emotions.
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Conclusion: The present findings suggest that a small number of ayahuasca sessions
can be as effective at improving acceptance as more lengthy and costly interventions.
Future studies should address the benefits of combining ayahuasca administration
with mindfulness-based interventions. This will allow us to investigate if ayahuasca will
improve the outcome of psychotherapeutic interventions.
Keywords: ayahuasca, mindfulness, acceptance, Non-Judging, human
INTRODUCTION
In recent years there has been a renewed interest in the potential
use of psychedelics for the treatment of different psychiatric
conditions (Sessa, 2005; Mithoefer et al., 2016). One of the
substances that have gained attention is ayahuasca; a tea obtained
from the mix of Banisteriopsis caapi with Psychotria viridis
(Rubiaceae) or Diplopterys cabrerana (Malpighiaceae) (McKenna
et al., 1984). The β-carboline alkaloids present in ayahuasca
[i.e., harmine, tetrahydroharmine (THH), and harmaline] show
monoamine-oxidase (MAO) inhibiting properties (Buckholtz
and Boggan, 1977b) and also serotonin reuptake inhibition
(THH; Buckholtz and Boggan, 1977a). The leaves of P. viridis
and D. cabrerana contain N,N-dimethyltryptamine (DMT),
an alkaloid that is also extracted into the ayahuasca brew
during the infusion process. DMT is the main psychotropic
agent of ayahuasca, and possibly the responsible for the
dream-like experience induced by the tea. This modified state
of consciousness is characterized by the presence of visual
imagery and the recollection of highly emotional autobiographic
memories (Riba et al., 2001). On a molecular level, DMT
has affinity for 5-HT2A and 5-HT1A binding sites, where
it acts as an agonist or partial agonist (Riba et al., 2001;
Carbonaro et al., 2015). Although DMT has been regarded as
the primary ayahuasca compound acting on the CNS, recent
research has shown that the β-carbolines may also have a
relevant contribution to the overall effects of ayahuasca in the
brain. Specifically, harmine, THH, and the harmine metabolite
harmol, stimulate adult neurogenesis in vitro (Morales-García
et al., 2017). Traditionally, ayahuasca has been consumed for
ritual and medical purposes in the Amazon Basin. Today
its use has spread worldwide, encouraging research on its
potential therapeutic effects (Domínguez-Clavé et al., 2016).
Compared to non-users, habitual ayahuasca consumers show
lower hopelessness (Santos et al., 2007) and depression levels,
and higher scores on certain personality traits like agreeableness
and openness (Barbosa et al., 2016). Experimental studies of
acute ayahuasca administration to healthy volunteers have found
that ayahuasca targets key nodes of the default mode network
(Valle et al., 2016; Sampedro et al., 2017) that are associated
with higher self-consciousness and pathological ruminations
(Vogt and Laureys, 2005). Additionally, data shows increased
blood flow in several brain regions implicated in cognitive
control, emotion regulation, and memory (Riba et al., 2006;
Sanches et al., 2016). Recent clinical studies on its utility as
an adjunct to psychological interventions have demonstrated
therapeutic benefits in treatment-resistant depression (Osório
Fde et al., 2015; Dos Santos et al., 2016; Sanches et al., 2016)
and substance abuse (Fábregas et al., 2010; Thomas et al.,
2013).
In a previous work by our group (Soler et al., 2016), we argued
that the therapeutic effects of ayahuasca might be related to
increases in mindfulness-related capacities. Mindfulness entails
a focus on the present experience and reaching a state of non-
judgmental awareness, enhanced curiosity and openness (Kabat-
Zinn, 1990; Bishop et al., 2004; Baer et al., 2006). These qualities
can be considered from a dimensional trait perspective, but can
also be fostered through meditative practice. In the last three
decades there has been a proliferation of mindfulness-based
interventions designed to teach individuals how to maximize
these skills. Probably the most commonly used intervention is
the Mindfulness-Based Stress Reduction (MBSR; Kabat-Zinn,
1990) approach, an 8-week program that has been widely applied
to deal with a number of medical and psychiatric conditions.
MBSR focuses on the cultivation of mindfulness through formal
meditation practices (i.e., body scan, sitting meditation and
yoga), and on the integration of mindfulness-principles into
everyday activities (Kabat-Zinn, 1990). In our previous study
(Soler et al., 2016), we assessed mindfulness-related capacities
before and after one dose of ayahuasca, finding that ayahuasca
intake led to increases in three core mindfulness facets:
decentering, defined as the capacity to observe one’s thoughts
and inner experiences in a detached manner (Fresco et al.,
2007); Non-Judging and Non-Reacting, defined, respectively,
as the ability to take non-judgmental and non-reactive stances
toward emotions, thoughts and experiences in general (Baer
et al., 2006). Moreover, in a subsequent study using magnetic
resonance imaging (MRI) we reported that post-acute metabolic
and connectivity changes in the brain after a single ayahuasca
session were associated with maintained elevations in the non-
judgmental attitudes 2 months later (Sampedro et al., 2017).
Together, the above data indicates that traditional mindfulness
training techniques are not the only pathway to foster
mindfulness capacities. They further suggest that ayahuasca
intake may attain analogous results (Soler et al., 2016). However,
the specific domains targeted by either approach have not been
assessed. Here, we conducted an exploratory-comparison study
in order to evaluate the similarities and differences of the two
approaches. Specifically, we compared the impact on mindfulness
scores of: (a) participation in four consecutive ayahuasca sessions
without the specific purpose of improving mindfulness capacities;
and (b) participation in a standard mindfulness training course (8
weeks MBSR), with the specific goal of improving these skills. We
hypothesized that both interventions would result in significant
improvements in mindfulness capacities. However, given the
lack of previous research comparing these two interventions
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hypotheses in regards to changes in specific-mindfulness facets
were not made.
MATERIALS AND METHODS
Participants
A total of 20 individuals (ten per group) were enrolled in the
study. Groups were comparable in terms of age [ayahuasca
group mean age = 50.00 years (SD = 14.71); MBSR group mean
age = 42.00 years (SD = 11.44; F = 1.84, p = 0.19)] and sex
(seven females in each group). Based on a previous study (Soler
et al., 2016) where ayahuasca users demonstrated unusually high
baseline scores on decentering, as measured by the Experiences
Questionnaire (EQ), we used the single-factor EQ scale to match
participants between groups. Table 1 shows that there were not
baseline differences between ayahuasca and MBSR groups in
neither FFMQ facets or the EQ.
Individuals interested in participating in more than one
ayahuasca session were contacted and received information about
the study aims. They were also asked to pass the information to
their acquaintances. The participant’s principal motivation was
to use ayahuasca to increase self-knowledge and introspection.
To be included in the study, participants in the ayahuasca group
needed to: (1) have abstained from ayahuasca, medications or
illicit drugs at least 2 weeks before the initial assessment, (2) have
abstained from alcohol, in the 24 h prior to the initial and final
assessments; and (3) agree to abstain from taking any drug other
than ayahuasca for the entire duration of the study. To increase
recruitment success, prior experience with ayahuasca was not
an exclusion criterion. No participant in the ayahuasca group
reported having any meditation experience.
The mindfulness group consisted of individuals naïve to
meditation who were interested in mindfulness and who had
enrolled in a MBSR course. The study’s aims were explained to
them before the beginning of the course. Inclusion criteria for
the MBSR group were: (1) no history of ayahuasca consumption;
(2) no alcohol intake in the 24 h prior to the initial and
final assessments; and (3) agree to abstain from taking any
psychoactive drug for the entire duration of the study.
TABLE 1 | Differences in FFMQ and EQ baseline scores between participants in
the ayahuasca group and participants in the mindfulness group.
Ayahuasca (n = 10) MBSR (n = 10)
M SD M SD F p
FFMQ
Observing 25.70 8.08 25.10 1.72 0.05 0.82
Describing 29.00 9.36 26.50 2.01 0.68 0.42
Acting with awareness 30.70 6.36 26.90 0.87 3.50 0.80
Non-Judging 30.00 9.32 27.10 0.73 0.96 0.34
Non-Reacting 22.00 8.39 23.40 1.77 0.26 0.61
EQ 38.00 9.62 39.00 3.49 0.09 0.76
MBSR, Mindfulness-Based Stress Reduction; M, Mean; SD, Standard Deviation;
FFMQ, Five Facets Mindfulness Questionnaire; EQ, Experiences Questionnaire.
The study was conducted in accordance with the Declaration
of Helsinki and was approved by the Sant Pau Hospital Ethics
Committee. All participants gave their written informed consent
prior to participation.
Study Groups
Ayahuasca Group
Participants were recruited from a pool of individuals who
had freely decided to participate in ayahuasca sessions in the
Barcelona area, in a non-religious setting. Ayahuasca was taken
in a dimly light room with participants sitting or lying down on
mattresses while recorded music was played. Participants were
free to leave the room if they so desired. Experimenters were
present before, during, and after each session, sessions lasted
between 6 and 8 h. Questionnaires were administered before the
first and 24 h after the last of four consecutive sessions held a week
apart.
MBSR Group
Participants in this group participated in a standard MBSR
program consisting of weekly 2.5 h sessions for eight consecutive
weeks. Training was conducted according to the MBSR guidelines
(Kabat-Zinn, 1990). During the 8 weeks participants were trained
in three types of mindfulness techniques. Through “body scan,”
participants learn to focus attention sequentially on parts of
the body, non-judgmentally noticing any sensation that might
be present. The second technique involves practicing mindful
hatha yoga postures to develop body awareness through gentle
movements and stretching. The third, “sitting meditation”
involves using awareness of the sensations associated with
breathing as an anchor, while noticing other bodily sensations,
sounds or thoughts. In the course of the program participants
were also encouraged to conduct informal mindfulness exercises,
by carrying out everyday activities (e.g., eating, walking, washing
the dishes) with a full awareness of the movements, sensations,
cognitions, and feelings that may be involved in each particular
task. CD’s containing recorded formal meditation practices were
given to participants, who were encouraged to practice at home
by listening to the CD 45 min each day throughout the duration
of the program (Kabat-Zinn, 1990). Between sessions 5 and 6,
individuals participated in a “day of silence” during which they
were guided through various practices. Participants in the MBSR
group filled out the administered questionnaires 24 h prior to the
first MBSR session and after the eighth and final MBSR session.
Measures
To assess mindfulness-related capacities the Spanish versions of
two instruments were used.
The Five Facet Mindfulness Questionnaire or FFMQ (Baer
et al., 2006; Cebolla et al., 2012) is a self-reported questionnaire
that measures five mindfulness components: (1) Observing:
noticing external and internal experiences, e.g., body sensations,
thoughts or emotions; (2) Describing: putting words to, or
labeling the internal experience; (3) Acting with awareness:
focusing on the present activity instead of behaving mechanically;
(4) Non-Judging the inner experience: taking a non-evaluative
stance toward the present experience, thoughts or emotions; and
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(5) Non-Reacting to the inner experience: allowing thoughts and
feelings to come, without getting caught up in, or carried away, by
them. Sample items for each sub-scale include: Observing “When
I take a shower or bath, I stay alert to the sensations of water
on my body”; Describing “I’m good at finding words to describe
my feelings”; Acting with awareness “I am easily distracted”;
Non-Judging “I tell myself I should not be feeling the way I am
feeling”; and Non-Reacting “I watch my feelings without getting
lost in them.” Study participants were asked to rate the degree
of agreement with each statement on a 5-point scale that ranges
from 1 (never, or very rarely true) to 5 (very often, or always, true).
After reverse scoring specific items, mean ratings are calculated
for each of the five facets. Facet scores range from 8 to 40, with
the exception of the non-reactivity facet, which ranges from 7 to
35 and higher scores reflect greater mindfulness.
The “Non-Judging” and “Non-Reacting” factors represent the
“acceptance” component of the FFMQ, while the other factors are
more related to the attentional aspect of mindfulness (Baer et al.,
2006).
The EQ (Fresco et al., 2007; Soler et al., 2014b) was used as
a measure of decentering. The EQ has 11 items and measures a
metacognitive ability known as “decentering,” i.e., the capacity
to observe one’s thoughts and emotions in a detached manner,
considering them transient events of the mind. Sample items
include: “I can observe unpleasant feelings without being drawn
into them” or “I can separate myself from my thoughts and
feelings.” The EQ items are scored in a 5-point scale, ranging
from never to all the time, with higher scores indicating more
decentering. EQ scores are obtained by adding the scores of each
item and dividing them by the total number of items.
The MINDSENS Composite Index was also calculated (Soler
et al., 2014a). This index includes those EQ and FFMQ items that
have proven to be the most sensitive to meditation practice (Soler
et al., 2014a). The MINDSENS Composite Index is the average
of the sum of 9 items of the EQ and 10 items of the FFMQ
(corresponding to the observing and non-reacting sub-scales;
Soler et al., 2014a).
Data Analysis
Between groups differences at pre-intervention in mindfulness
scores (FFMQ and EQ) were explored by means of an ANOVA.
FFMQ, EQ, and MINDSENS scores were analyzed by means
of multivariate (FFMQ subscale scores) and univariate (EQ
and MINDSENS scores) repeated-measures analyses of variance
(ANOVAs). FFMQ subscale scores, EQ scores and MINDSENS
scores were entered in the respective ANOVAs as the dependent
variables. Participant group (ayahuasca vs. mindfulness) was
entered as a between-subjects factor and time (pre- and post-
assessment) as a within subject’s factor. Post hoc analyses
were conducted using Student’s t-test. Results were considered
significant for p-values < 0.05.
RESULTS
The multivariate-repeated measures ANOVA using FFMQ’s
scores as the dependent variables showed a significant effect
of time × group [F(5,14) = 5.16, p = 0.007]. Univariate tests
showed a significant time × group effect for the following
FFMQ facets: Observing [F(1,19) = 22.60, p < 0.001], Describing
[F(1,19) = 13.61, p = 0.00], Acting with awareness [F(1,19) = 8.52,
p = 0.01], and Non-Reacting [F(1,19) = 6.50, p = 0.02]. For
scores on Non-Judging no significant time × group effect was
found [F(1,19) = 3.43, p = 0.08]. Participants in the mindfulness
group showed significant pre–post treatment increases in all
mindfulness facets: Observing [t(9) = −17.14, p < 0.001],
Describing [t(9) = −9.18, p < 0.001], Acting with awareness
[t(9) = −18.46, p < 0.001], Non-judging [t(9) = −14.95,
p < 0.001], and Non-Reacting [t(9) = −8.15, p < 0.001]. In
the ayahuasca group a significant pre–post improvement was
found for Non-Judging [t(9) = −2.67, p = 0.02], while no
significant pre–post differences were observed for the remaining
FFMQ facets: Observing [t(9) = −1.10, p = 0.29], Describing
[t(9) = −1.45, p = 0.17], Acting with awareness [t(9) = −1.86,
p = 0.09], and Non-Reacting [t(9) = −1.23, p = 0.25].
For EQ scores a significant time × group interaction
was found [F(1,18) = 7.87, p = 0.01] and post hoc analyses
showed significant pre–post differences in the mindfulness group
[t(9) = −9.63, p < 0.001], whereas no significant differences were
found for the ayahuasca group [t(9) = −1.82, p = 0.10].
The ANOVA for the MINDSENS Composite Index also
revealed a significant time × group effect [F(1,18) = 21.13,
p < 0.001]. Post hoc analyses showed significant differences in
the mindfulness group [t(9) = −17.84, p < 0.001], but not in the
ayahuasca group [t(9) = −1.50, p = 0.17]. Table 2 and Figure 1
show pre–post mindfulness scores for each group.
DISCUSSION
The current study aimed to better understand the psychological
mechanisms related to ayahuasca’s therapeutic effects by studying
its impact on mindfulness-related capacities. Extending our
previous work (Soler et al., 2016), here we compared the
effects of four consecutive ayahuasca sessions with those of
a standard mindfulness training. Whereas individuals in the
ayahuasca group had decided to take the psychedelic for
personal reasons unrelated to the objectives of our study,
those receiving standard mindfulness training (i.e., MBSR), had
enrolled in the program with the specific purpose of improving
their mindfulness capacities. Results showed that mindfulness
training had an overall greater impact on mindfulness capacities.
However, ayahuasca intake led to spontaneous increases in
certain aspects of the “acceptance” domain, as measured by
the Non-Judging subscale of the FFMQ. Acceptance is one
the psychological spheres cultivated in mindfulness meditation
and in mindfulness-based psychotherapy. Increasing acceptance
enables the individual to attain a non-evaluative stance toward
their experience of “being,” their thoughts and their emotions
without getting carried away by them, no matter how painful
these may be.
Our results concerning the Non-Judging subscale replicate
the findings obtained by our group in two prior independent
studies that assessed ayahuasca users after a single session
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TABLE 2 | Comparison of FFMQ and EQ scores between participants in the ayahuasca group and participants in the mindfulness group.
Ayahuasca (n = 10) MBSR (n = 10)
Pre Post Pre Post Group × time
M SD M SD M SD M SD F p
FFMQ
Observing 25.70 8.08 27.60 9.38 25.10 1.72 35.70∗∗ 1.33 22.60 < 0.001
Describing 29.00 9.36 31.40 6.73 26.50 2.01 36.10∗∗ 1.52 13.61 0.00
Acting with awareness 30.70 6.36 34.10 4.81 26.90 0.87 35.80∗∗ 1.13 8.52 0.01
Non-Judging 30.00 9.32 34.50∗ 5.66 27.10 0.73 35.50∗∗ 1.43 3.43 0.08
Non-Reacting 22.00 8.39 24.20 6.30 23.40 1.77 30.70∗∗ 1.63 6.50 0.02
EQ 38.00 9.62 42.10 5.66 39.00 3.49 50.20∗∗ 3.35 7.87 0.01
MINDSENS 3.33 0.91 3.61 0.74 3.31 0.16 4.50∗∗ 0.19 21.13 < 0.001
MBSR, Mindfulness-Based Stress Reduction; M, Mean; SD, Standard Deviation; FFMQ, Five Facets Mindfulness Questionnaire; EQ, Experiences Questionnaire ∗p< 0.05;
∗∗p < 0.001.
FIGURE 1 | Pre–post changes in FFMQ facets and decentering scores (Experiences Questionnaire) in group A (ayahuasca intake) and group B (mindfulness
training). Values are shown as means with standard errors represented by vertical bars.
(Soler et al., 2016; Sampedro et al., 2017). In both cases,
ayahuasca increased the scores on the Non-Judging and Non-
Reacting subscales of the FFMQ, which focus on the “acceptance”
domain of mindfulness abilities. Similar to our present results,
these previous studies did not find any effect of ayahuasca on
the other three subscales of the FFMQ that assess the “attention”
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domain of mindfulness abilities. Interestingly, in the Sampedro
et al. (2017) study a follow-up assessment was carried out
2 months after the ayahuasca session and found that Non-
Judging was the only subscale that remained elevated (Sampedro
et al., 2017). The present findings thus further support for
the following ideas: (a) ayahuasca intake leads to psychological
modifications that are observable beyond the time frame of the
acute inebriation; and (b) a reduction in self-judgmental patterns
of thought is a key feature of the post-acute stage.
A novel and relevant finding in the present investigation
is that both ayahuasca and MBSR produce improvement in
acceptance, although only the latter -MBSR- is a theoretical
and practical training program specifically designed to foster
mindfulness domains (Gu et al., 2015; Khoury et al., 2015).
While individuals in the ayahuasca group may have had a
wide variety of reasons to engage in ayahuasca taking, subjects
in the comparison group had enrolled in the MBSR course
with the explicit purpose of enhancing mindfulness capacities.
Importantly, ayahuasca would thus appear to have the potential
to increase acceptance per se, without this being a manifest
and desired outcome of ayahuasca intake. Although studies
with larger sample size are needed, the above finding is
relevant for a number of reasons, theoretical and clinical. First,
reducing automatic judgmental attitudes is particularly hard
to achieve. Montero-Marin et al. (2016) found improvements
in Observing, Non-Reacting, decentering and non-attachment
in individuals who had participated in a 1-month meditation
retreat, but failed to find modifications in Non-Judging. In
another study, the authors assessed the influence of practice
(i.e., frequency of meditation, session duration, lifetime practice)
on various mindfulness facets. Results showed that Non-
Judging improved with practice significantly less than Non-
Reacting, Observing and decentering (Soler et al., 2014a).
Second, acceptance has been found to play a fundamental
role in psychological health. Non-judgmental awareness is
commonly impaired in diverse clinical populations (Coffey
et al., 2010). Deficits have been reported for individuals with
eating disorders (Lavender et al., 2011), borderline personality
disorder (Baer et al., 2004), and cocaine use disorder (Tejedor
et al., 2014). Moreover, Brown et al. (2015) have found
an association between higher Non-Judging capacities and
lower depressive symptoms and anxiety. Kotsou et al. (2018),
showed that higher acceptance is a better predictor of lower
psychopathology than other variables related to mental health
such as emotional competence, emotion regulation or even
present-centered awareness. Interestingly, increasing acceptance
has been directly linked to the positive outcomes of mindfulness
practice (Holzel et al., 2011), and of exposure interventions
(Brown et al., 2015). The acute stage of ayahuasca has been
assimilated to a controlled exposure to autobiographical material
(Domínguez-Clavé et al., 2016). Our results suggest that acute
exposure is followed by a subsequent stage of increased
acceptance. These combined effects could be of great value
in a psychotherapeutic context (Domínguez-Clavé et al., 2016;
Mithoefer et al., 2016).
From a neurobiological perspective, our findings can be
linked to the selective modulation by ayahuasca of specific
brain regions and networks. In a neuroimaging study using
MRI, we found associations between Non-Judging increases and
post-acute neurometabolic and connectivity changes (Sampedro
et al., 2017). Reductions in the levels of the excitatory glutamate–
glutamine complex in the posterior cingulate cortex (PCC)
correlated with Non-Judging increases 24 h after ayahuasca
intake and at follow-up 2 months later. In the same study,
increased functional connectivity between the anterior cingulate
cortex (ACC) and the PCC and between the ACC and
the medial temporal lobe (MTL) also correlated with Non-
Judging at the two assessment time points. Thus, desirable
effects at the psychological level were linked on the one
hand to neurometabolic reductions in the PCC, a region
which is key to the sense of self (Vogt and Laureys, 2005)
and is abnormally hyperactive in certain psychiatric conditions
(Hamilton et al., 2011). On the other hand, enhanced Non-
Judging relied also on increased neural network cross-talk and on
an increased coupling of activity between the ACC, a key center
of self-monitoring and other aspects of executive function (Kelly
et al., 2009) and the MTL, a limbic region processing memory and
emotion (Dolcos et al., 2004).
Contrary to our previous findings (Soler et al., 2016; Sampedro
et al., 2017), scores on the Non-Reacting subscale of the FFMQ
and on the EQ questionnaire (decentering) were not significantly
modified after ayahuasca. These discrepancies may indicate a less
robust effect of ayahuasca on these variables. As a matter of fact,
in our previous neuroimaging study we found that post-acute
increases in these variables had returned to baseline levels 2
months later, while scores on Non-Judging remained elevated
(Sampedro et al., 2017). Another possible explanation could be
that Non-Judging is difficult to increase and thus less prone to
show ceiling effects or erratic behavior (see limitations paragraph
below). The fact that ayahuasca users were only assessed twice,
i.e., before and after fourth ayahuasca session may have prevented
us from detecting these potential problems. This brings up the
question of the potential impact of the pattern of ayahuasca
consumption (e.g., frequency, amount, time between intakes)
on the modulation of each mindfulness facet and domain. This
question warrants further research in order to optimize the
number of ayahuasca sessions and the spacing between sessions
in future therapeutic studies.
The observational and exploratory nature of our study
involved several limitations that need to be mentioned. The
main limitation of the present study was the small sample
size that limited the statistical power of the study. Assessments
were only conducted, respectively, before the first and after the
fourth ayahuasca session, and before and at the end of the
MBSR course. No assessments were conducted in between. This
approach was selected to avoid imposing an excessive burden
on the ayahuasca-using participants that might have led to
high drop-out levels. The fact that individuals in the ayahuasca
group had prior experience with this psychedelic may have led
to ceiling effects on the study variables. On the other hand,
the higher scores obtained for several variables in the MBSR
group may have been biased by the fact that participants in
the mindfulness training course had the explicit intention of
enhancing their mindfulness capacities. Ideally, future studies
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could assign ayahuasca-naïve and meditation-nature participants
to either group randomly. In order to shorten the assessment,
we did not explore subjective effects of ayahuasca intake nor the
specific motivations to attend to ayahuasca sessions. In addition,
including a placebo control group for the ayahuasca condition
could also have been interesting to assess possible placebo effects.
Assessments could be conducted in both groups at several time
points along the study period and follow-up data gathered
in order to determine the temporal stability of the findings.
Additionally, the design of the study did not include alkaloid
determinations in the ayahuasca used by the participants. Lastly,
and although participants did not report any current psychiatric
disorder or medical condition, no formal medical history was
obtained.
CONCLUSION
To conclude, the present results suggest that the “acceptance”
domain of mindfulness capacities is particularly sensitive to
improvement by ayahuasca, and potentially other psychedelics.
Together with previous findings (Soler et al., 2016; Sampedro
et al., 2017), the current results open the interesting possibility
of using ayahuasca as a tool to enhance acceptance in the
context of psychotherapy. Our findings indicate that a small
number of ayahuasca sessions could be effective at improving
acceptance, similarly to more lengthy and costly interventions.
The present findings should be interpreted in light of the
aforementioned limitations. The small sample size compromised
the statistical power of the study, increasing the possibility of
false positive and false negatives. Studies with a larger sample
size are needed to confirm the findings of this exploratory
study. Future studies should address the benefits of combining
ayahuasca administration with mindfulness-based interventions,
in order to investigate if ayahuasca will improve the outcome of
these psychotherapeutic interventions.
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